Endocrinology, Vol 134, 2064-2071, Copyright © 1994 by Endocrine Society

ARTICLES

Developmental regulation of glucocorticoid-mediated effects on extracellular matrix protein expression in the human placenta

S Guller, L Markiewicz, R Wozniak, JM Burnham, EY Wang, P Kaplan and CJ Lockwood
Department of Obstetrics/Gynecology and Reproductive Science, Mt. Sinai Medical Center, New York, New York 10029.

The extracellular matrix (ECM) protein fibronectin (FN) is a critical regulator of uterine-placental adherence. In the present report we compared the effects of glucocorticoids on FN expression in cytotrophoblast cultures isolated from human first trimester and term placentas to elucidate potential steroid-dependent cellular mechanisms associated with human parturition. Based on immunoassays, treatment of first trimester cytotrophoblasts with 10(-7) M dexamethasone (DEX) for 2 cr 4 days reduced medium levels of oncofetal FN (onfFN; i.e. FNs bearing an oncofetal epitope) to approximately 80% of control levels. Conversely, treatment of cytotrophoblasts isolated from term placentas with DEX dramatically reduced medium levels of onfFN to approximately 12% of control values. Treatment of both first trimester and term cells with 10(-6) M progestin, mineralocorticoid, or estrogen had no significant effect on onfFN expression in either cell type. Glucocorticoids specifically down-regulated medium levels of onfFN in term cells, but not in first trimester cells. In contrast, DEX treatment promoted an approximately 3- to 7-fold increase in levels of hCG in both first trimester and term cytotrophoblasts, suggesting that the effects of glucocorticoid on FN and hCG expression are elicited through independent cell-signaling pathways. In first trimester cells, DEX promoted a reduction in rates of FN and laminin synthesis to 60-70% of control levels. In term cells, DEX treatment reduced levels of FN and laminin synthesis to approximately 10% of control levels. Similarly, DEX treatment down-regulated levels of FN mRNA to approximately 60% and 10% of control values in first trimester and term cells, respectively. The first trimester of human pregnancy is associated with low levels of glucocorticoids and reduced glucocorticoid responsiveness. These conditions would favor high levels of placental ECM protein synthesis, thus stabilizing uterine-placental adherence. Conversely, elevated levels of glucocorticoids near parturition and increased glucocorticoid responsiveness would inhibit placental ECM protein synthesis, reducing uterine-placental adherence and promoting the separation of placenta from uterus.

This article has been cited by other articles:

				A. E. Michael and A. T. Papageorghiou Potential significance of physiological and pharmacological glucocorticoids in early pregnancy Hum. Reprod. Update, September 1, 2008; 14(5): 497 - 517. [Abstract] [Full Text] [PDF]

				M Mandl, N Ghaffari-Tabrizi, J Haas, G Nohammer, and G Desoye Differential glucocorticoid effects on proliferation and invasion of human trophoblast cell lines Reproduction, July 1, 2006; 132(1): 159 - 167. [Abstract] [Full Text] [PDF]

				M.-J. Lee, Y. Ma, L. LaChapelle, S. S. Kadner, and S. Guller Glucocorticoid Enhances Transforming Growth Factor-{beta} Effects on Extracellular Matrix Protein Expression in Human Placental Mesenchymal Cells Biol Reprod, May 1, 2004; 70(5): 1246 - 1252. [Abstract] [Full Text] [PDF]

				Y. Ma, C. J. Lockwood, A. L. Bunim, D. A. Giussani, P. W. Nathanielsz, and S. Guller Cell Type-Specific Regulation of Fetal Fibronectin Expression in Amnion: Conservation of Glucocorticoid Responsiveness in Human and Nonhuman Primates Biol Reprod, June 1, 2000; 62(6): 1812 - 1817. [Abstract] [Full Text]

				I. Olazabal, J. Muñoz, S. Ogueta, E. Obregón, and J. P. García-Ruiz Prolactin (PRL)-PRL Receptor System Increases Cell Proliferation Involving JNK (c-Jun Amino Terminal Kinase) and AP-1 Activation: Inhibition by Glucocorticoids Mol. Endocrinol., April 1, 2000; 14(4): 564 - 575. [Abstract] [Full Text]

				J. S. Ryu, R. J. Majeska, Y. Ma, L. LaChapelle, and S. Guller Steroid Regulation of Human Placental Integrins: Suppression of {alpha}2 Integrin Expression in Cytotrophoblasts by Glucocorticoids Endocrinology, September 1, 1999; 140(9): 3904 - 3908. [Abstract] [Full Text]

				T. Rosen, G. Krikun, Y. Ma, E.-Y. Wang, C. J. Lockwood, and S. Guller Chronic Antagonism of Nuclear Factor-{kappa}B Activity in Cytotrophoblasts by Dexamethasone: A Potential Mechanism for Antiinflammatory Action of Glucocorticoids in Human Placenta J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3647 - 3652. [Abstract] [Full Text]

				D. Y. Yoon, Y. Ma, G. Krikun, C. J. Lockwood, L. LaChapelle, and S. Guller Glucocorticoid Effects in the Human Placenta: Evidence That Dexamethasone-Mediated Inhibition of Fibronectin Expression in Cytotrophoblasts Involves a Protein Intermediate J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 632 - 637. [Abstract] [Full Text]

				R. Runic, C. J. Lockwood, L. LaChapelle, B. Dipasquale, R. I. Demopoulos, A. Kumar, and S. Guller Apoptosis and Fas Expression in Human Fetal Membranes J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 660 - 666. [Abstract] [Full Text]

				G. M. Jackson, S. S. Edwin, M. W. Varner, D. Casal, and M. D. MItchell Regulation of Fetal Fibronectin Production in Human Amnion Cells Reproductive Sciences, March 1, 1996; 3(2): 85 - 88. [Abstract] [PDF]